Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Senores Pharmaceuticals has informed that it enclosed a Media Release in relation to the Consolidated and Standalone Un-audited financial results of the company for the quarter and nine months ended December 31, 2024 duly approved by the Board of Directors of the Company in their meeting held on January 23, 2025.
The above information is a part of company’s filings submitted to BSE.
